The Competition Commission on Wednesday slapped sanctions for a total of almost RS 2.70 million rupees and sanctions not established in UVNIZ, India, its subsidiary digital scrabble, and qube cinema technologies for unfair commercial practices. UFO Moviez and Qube were important players in the relevant market for the supply of digital film initiatives, digital film teams (DCE) that meet the lease/rental of film theater owners (CTO) in the country.
The managing director of Fintech Firm One97 Communications (PayTM) and executive director Vijay Shekhara has voluntarily delivered 2.1 million shares worth approximately 1.8 billion rupees, according to a regulatory presentation and the closing price of the company’s shares. The actions were granted to Sharma as part of ESOP (employee -sharing ownership) at the time of the One97 Communications list, which the PayTM brand has. Now he will return to the ESOP group under a scheme of actions of 97 employees, 2019.
Zaggy Prepaid Ocean Services Limited has announced that he has assured an approval of supplier of third -party requests (TPPP) of the National Payment Corporation of India (NPCI). The development will allow Zaggy to offer pay -based payment solutions directly through its platform, empowering 3 million users committed to its digital ecosystem, the company said in a statement.
DLF has sold its Ti-Sez project (special economic zone) in Kolkata for RS 693 million rupees to Srijan Group as part of its strategy to monetize commercial assets.
Ultratech cement on Wednesday said it will acquire 26 % of renewable energy generation shares and the transmission firm AMPIN C&I Power Eight. The acquisition, aimed at satisfying the company’s green energy needs, will have a capital investment of up to RS 25.50 million rupees, according to a regulatory presentation of the company of the Aditya Birla group.
The Competition Commission of India (CCI) has eliminated a proposal by Patanjali Ayurved and five other entities to acquire a majority participation in Magma General Insurance. “The proposed combination is being notified under the green channel route in the consonance with section 6 (4) of the 2002 Competition Law,” CCI said in a notice. According to the green channel route, it is considered that a transaction that does not present any risk of an appreciable advertising effect in the competition is considered approved in the bee intimidated to the competition control agency.
The US Health Regulator. Has raised the Biofarma Aspen laboratories for various manufacturing lapses in its production installation of active pharmaceutical ingredients in Telangana. In a warning letter to its CEO K Sateesh Reddy, the United States Food and Medicines Administration (USFDA) said the pharmacological firm could not design and build buildings and facilities used in the manufacture of API in a way to minimize potential pollution, facilities.
Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the next launch of dextroanfetamine, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets (mixed salts of a single amphetamine product), 5 mg, 10 mg, 15 mg, 15 mg, 20 mg, 20 mg, 20 mg. Glenmark dextrohaphetamine saca -skeleton, amphetamine aspartate, dextramphetamine sulfate and amphetamine sulfate tablets (mixed salts from an amphetamine product of a single entity), 5 mg, 10 mg, 15 mg, 20 mg and 30 mg and triplicate. Drugs, Tablets Adderall, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg, or Teva Women’s Health, Inc. and the company will begin the distribution in May 2025.
Tanla Platforms has been associated with two telecommunications companies abroad for the deployment of its messenger as a platform (MAAP) for rich media messages, marking the first deployment of the company outside of India. This platform will be commercial live in quarter 1 of the financial year 2026 with the two telecommunications.
Lupin informed the exchanges that the United States District Court for the District of Delaware has approved an order in the matter of the myrbetriq patents. On April 15, 2025, the Court ruled in favor of Astellas Pharma regarding the validity of its American patent No. 10,842,780. The Court indicated that the problems of whether Lupin’s products violate the 780 patent, additional damage and disability theories will be litigated in a judgment with a semi -jury in 2026.
Bharat Heavy Electrics Limited (BHEL) has signed a ‘Technology Transfer Agreement (TTA) with the Bhabha Atomic Research Center for the mixed matrix membrane diaphragm for separating applications in electrochemical cells.
Home First Finance Company India has successfully collected a fresh capital of ₹ 1,250 million rupees through the issuance of 1.3 million capital shares to institutional buyers qualified through a placement of qualified institutes
Posted on April 17, 2025